RE:RE:Spiking in pre-market!I get what you are saying but it worth remembering the stock is up about 40% this year. The market is giving them at least some minimal value for cancer. And there are catalysts for the stock price right on the horizon - the R&D day in the second week of September (they better formally announce this soon so people can get it on their calendars) could attract new potential buyers to the stock, we do not know when in the fourth quarter they will release preliminary efficacy and safety info on the phase 1A but it is coming soon and we will likely get a finalized NASH partnership before the end of the year as well. So, there are some very sginificant catalysts just ahead. They are also speaking at a Cantor conference in late September which may get them some new investors. Also, there are normally a lot of medical and investor conferences in the Falland I am sure they will be at some of those. You also never know when they might announce some new medical finding on cancer.
PWIB123 wrote: I'm getting the impression we should expect no real price movement with this stock until the first of next year when we learn whatever we are going to learn. Love the prospects, hate watching this stock drop every day and then move back to even. Clearly, things are moving in the right direction. It would be nice to see at least some small upward movement over the course of the year. If the stock doens't move up any between time, it gives the feeling that you can keep waiting until we know more before pulling the trigger to invest. Upward price movement will incentivize more investors to come to the table.